MYLAN SM 12.5 MYLAN SM 12.5 Pill - brown capsule/oblong, 14mm

Pill with imprint MYLAN SM 12.5 MYLAN SM 12.5 is Brown, Capsule/Oblong and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Sunitinib is used in the treatment of Renal Cell Carcinoma; Pancreatic Cancer; Gastrointestinal Stromal Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN SM 12.5 MYLAN SM 12.5

Sunitinib Malate

Imprint: MYLAN SM 12.5 MYLAN SM 12.5
Strength: 12.5 mg
Color: Brown
Size: 14.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
National Drug Code (NDC): 00378-6678
Inactive Ingredients: silicon dioxide, croscarmellose sodium, gelatin, magnesium stearate, mannitol, sodium lauryl sulfate, titanium dioxide, ferric oxide red, ammonia, ferrosoferric oxide, propylene glycol, shellac
Note: Inactive ingredients may vary.